We found significantly higher expression of GDF11, ACVR2B, and SMAD2 mRNA in MDS hematopoietic stem and progenitor samples compared with those of the age-matched control participants (Figure 1A). This evidence concerns the gene ACVR2B and myelodysplastic syndrome.